124
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Analysis of Urinary Pathogen Cultures and Drug Sensitivity in Patients with Urinary Stones for Five Consecutive Years in Xiangya Hospital, China

ORCID Icon, , , &
Pages 1357-1363 | Published online: 11 May 2020

References

  • Miano R, Germani S, Vespasiani G. Stones and urinary tract infections. Urol Int. 2007;79(1):32–36. doi:10.1159/00010443917726350
  • Xu G, He Y, Zhao H, et al. Mini-nephroscope combined with pressure suction: an effective tool in MPCNL for intrarenal stones in patients with urinary tract infections. Urolithiasis. 2016;44(5):445–450. doi:10.1007/s00240-016-0859-826857367
  • Shi B, Hong X, Yu J. Management of unilateral staghorn renal stones with concurrent urinary tract infections by retroperitoneal laparoscopic pyelolithotomy with prolonged renal posterior lower segment incision. Exp Ther Med. 2019. doi:10.3892/etm.2019.7545
  • Li K, Liu C, Zhang X, Liu Y, Wang P. Risk factors for septic shock after mini-percutaneous nephrolithotripsy with holmium laser. Urology. 2013;81(6):1173–1176. doi:10.1016/j.urology.2013.01.03523499349
  • Yang X, Zhang D, Li Y, Chong T, Zhang P. Analysis on the risk factors for septic shock following minimally invasive percutaneous nephrolithotomy. Int J Clin Exp Med. 2018;11(5):4925–4930.
  • Wang CT, Hao B. Associated factors of SIRS and residual stones after flexible ureteroscopic holmium laser lithotripsy for calyceal diverticular stones. Chin Gen Pract. 2017;20(17):2079–2084.
  • Ma K, Xu QQ, Huang XB, et al. [Analysis and clinical implication of upper urinary tract stone’s bacterial spectrum]. Zhonghua Wai Ke Za Zhi. 2010;48(4):293–295.20388440
  • Dajani AM, Khadra ALIA. Urinary calculi and urinary tract infection In: Urolithiasis. Boston, MA:Springer; 1989:277–278.
  • Zhou J, Ma X. A survey on antimicrobial stewardship in 116 tertiary hospitals in China. Clin. Microbiol. Infect. 2019;25(6):759.e9–759.e14. doi:10.1016/j.cmi.2018.09.005
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement Clinical and Laboratory Standards Institute; 2011.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement Clinical and Laboratory Standards Institute; 2015.
  • CLSI. Performance standards for antimicrobial susceptibility testing: 26th informational supplement, document M100-S26. Clin Lab Stand Inst. 2016.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th CLSI supplement M100 Wayne, PA:: Clinical and Laboratory Standards Institute; 2017
  • CLSI. Performance standards for antimicrobial susceptibility testing performance standards for antimicrobial susceptibility testing suggested citation In: CLSI Doc. M02-A11. 2018.
  • Zeng S, Xu Z, Wang X, et al. Time series analysis of antibacterial usage and bacterial resistance in China: observations from a tertiary hospital from 2014 to 2018. Infect Drug Resist. 2019;12:2683–2691. doi:10.2147/IDR.S22018331695444
  • Zhang X, Lu Q, Liu T, Li Z, Cai W. Bacterial resistance trends among intraoperative bone culture of chronic osteomyelitis in an affiliated hospital of South China for twelve years. BMC Infect Dis. 2019;19(1). doi:10.1186/s12879-019-4460-y
  • Singh BR. Quinolones and fluoroquinolones are useless to counter uropathogenic Escherichia coli infections [letter]. Infect Drug Resist. 2019;12:2161–2162. doi:10.2147/IDR.S22039431410035
  • Chen L, Bu Q, Xu H, et al. The effect of berberine hydrochloride on Enterococcus faecalis biofilm formation and dispersion in vitro. Microbiol Res. 2016;186–187:44–51. doi:10.1016/j.micres.2016.03.003
  • Yan Q, Karau MJ, Patel R. In vitro activity of oritavancin against planktonic and biofilm states of vancomycin-susceptible and vancomycin-resistant enterococci. Diagn Microbiol Infect Dis. 2018;91(4):348–350. doi:10.1016/j.diagmicrobio.2018.03.00829678300
  • Liu J, Huang X, Liu Y, Xu H, Gong R, Li C. Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis. J Cent South Uni. 2016;41(12):1328–1333.
  • Kreydin EI, Eisner BH. Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol. 2013;10(10):598–605. doi:10.1038/nrurol.2013.18323999583
  • Marien T, Miller NL. Treatment of the infected stone. Urol Clin North Am. 2015;42(4):459–472. doi:10.1016/j.ucl.2015.05.00926475943
  • Margel D, Ehrlich Y, Brown N, Lask D, Livne PM, Lifshitz DA. Clinical implication of routine stone culture in percutaneous nephrolithotomy - A prospective study. Urology. 2006;67(1):26–29. doi:10.1016/j.urology.2005.08.00816413326